These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 23282186)

  • 1. Pseudo-plaque reduction neutralization test (PPRNT) for the measurement of neutralizing antibodies to Crimean-Congo hemorrhagic fever virus.
    Canakoglu N; Berber E; Ertek M; Yoruk MD; Tonbak S; Bolat Y; Aktas M; Kalkan A; Ozdarendeli A
    Virol J; 2013 Jan; 10():6. PubMed ID: 23282186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice.
    Hinkula J; Devignot S; Åkerström S; Karlberg H; Wattrang E; Bereczky S; Mousavi-Jazi M; Risinger C; Lindegren G; Vernersson C; Paweska J; van Vuren PJ; Blixt O; Brun A; Weber F; Mirazimi A
    J Virol; 2017 May; 91(10):. PubMed ID: 28250124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of two serological methods for detecting IgG and neutralizing antibodies against Crimean-Congo hemorrhagic fever virus glycoprotein.
    Wang Q; Wang S; Shi Z; Li Z; Zhao Y; Feng N; Wang T; Yan F; Xia X
    Front Cell Infect Microbiol; 2024; 14():1341332. PubMed ID: 38746783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of broadly neutralizing monoclonal antibodies against Crimean-Congo hemorrhagic fever virus.
    Zivcec M; Guerrero LIW; Albariño CG; Bergeron É; Nichol ST; Spiropoulou CF
    Antiviral Res; 2017 Oct; 146():112-120. PubMed ID: 28842265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the cell culture based and the mouse brain derived inactivated vaccines against Crimean-Congo hemorrhagic fever virus in transiently immune-suppressed (IS) mouse model.
    Pavel STI; Yetiskin H; Kalkan A; Ozdarendeli A
    PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008834. PubMed ID: 33226988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitive and specific detection of Crimean-Congo Hemorrhagic Fever Virus (CCHFV)-Specific IgM and IgG antibodies in human sera using recombinant CCHFV nucleoprotein as antigen in μ-capture and IgG immune complex (IC) ELISA tests.
    Emmerich P; Mika A; von Possel R; Rackow A; Liu Y; Schmitz H; Günther S; Sherifi K; Halili B; Jakupi X; Berisha L; Ahmeti S; Deschermeier C
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006366. PubMed ID: 29579040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models.
    Garrison AR; Shoemaker CJ; Golden JW; Fitzpatrick CJ; Suschak JJ; Richards MJ; Badger CV; Six CM; Martin JD; Hannaman D; Zivcec M; Bergeron E; Koehler JW; Schmaljohn CS
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005908. PubMed ID: 28922426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel double-antigen sandwich ELISA for the species-independent detection of Crimean-Congo hemorrhagic fever virus-specific antibodies.
    Sas MA; Comtet L; Donnet F; Mertens M; Vatansever Z; Tordo N; Pourquier P; Groschup MH
    Antiviral Res; 2018 Mar; 151():24-26. PubMed ID: 29330092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleoside-Modified mRNA Vaccines Protect IFNAR
    Appelberg S; John L; Pardi N; Végvári Á; Bereczky S; Ahlén G; Monteil V; Abdurahman S; Mikaeloff F; Beattie M; Tam Y; Sällberg M; Neogi U; Weissman D; Mirazimi A
    J Virol; 2022 Feb; 96(3):e0156821. PubMed ID: 34817199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A competitive ELISA for species-independent detection of Crimean-Congo hemorrhagic fever virus specific antibodies.
    Schuster I; Mertens M; Köllner B; Korytář T; Keller M; Hammerschmidt B; Müller T; Tordo N; Marianneau P; Mroz C; Rissmann M; Stroh E; Dähnert L; Hammerschmidt F; Ulrich RG; Groschup MH
    Antiviral Res; 2016 Oct; 134():161-166. PubMed ID: 27623345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of the pseudo-plaque assay for detection and titration of Crimean-Congo hemorrhagic fever virus.
    Berber E; Canakoglu N; Yoruk MD; Tonbak S; Aktas M; Ertek M; Bolat Y; Kalkan A; Ozdarendeli A
    J Virol Methods; 2013 Jan; 187(1):26-31. PubMed ID: 22906394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic fever.
    Fels JM; Maurer DP; Herbert AS; Wirchnianski AS; Vergnolle O; Cross RW; Abelson DM; Moyer CL; Mishra AK; Aguilan JT; Kuehne AI; Pauli NT; Bakken RR; Nyakatura EK; Hellert J; Quevedo G; Lobel L; Balinandi S; Lutwama JJ; Zeitlin L; Geisbert TW; Rey FA; Sidoli S; McLellan JS; Lai JR; Bornholdt ZA; Dye JM; Walker LM; Chandran K
    Cell; 2021 Jun; 184(13):3486-3501.e21. PubMed ID: 34077751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crimean-Congo Hemorrhagic Fever Virus, Mongolia, 2013-2014.
    Voorhees MA; Padilla SL; Jamsransuren D; Koehler JW; Delp KL; Adiyadorj D; Baasandagwa U; Jigjav B; Olschner SP; Minogue TD; Schoepp RJ
    Emerg Infect Dis; 2018 Dec; 24(12):2202-2209. PubMed ID: 30457521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crimean-Congo Hemorrhagic Fever Mouse Model Recapitulating Human Convalescence.
    Hawman DW; Meade-White K; Haddock E; Habib R; Scott D; Thomas T; Rosenke R; Feldmann H
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31292241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Convalescent human plasma candidate reference materials protect against Crimean-Congo haemorrhagic fever virus (CCHFV) challenge in an A129 mouse model.
    Kempster S; Hassall M; Graham V; Kennedy E; Findlay-Wilson S; Salguero FJ; Bagci B; Elaldi N; Oz M; Tasseten T; Charlton FW; Barr JN; Fontana J; Duru C; Ezeajughi E; Matejtschuk P; Arnold U; Adedeji Y; Mirazimi A; Hewson R; Dowall S; Almond N
    Virus Res; 2024 Aug; 346():199409. PubMed ID: 38815869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of PCR and ELISA-IgM results in the laboratory diagnosis of Crimean-Congo haemorrhagic fever cases in 2008 in Turkey].
    Uyar Y; Carhan A; Albayrak N; Altaş AB
    Mikrobiyol Bul; 2010 Jan; 44(1):57-64. PubMed ID: 20455399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of Crimean-Congo hemorrhagic fever virus in ruminant species slaughtered in several endemic provinces in Turkey.
    Ozan E; Ozkul A
    Arch Virol; 2020 Aug; 165(8):1759-1767. PubMed ID: 32435856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of an isolated case of human Crimean-Congo hemorrhagic fever in Central Uganda, 2015.
    Balinandi S; Patel K; Ojwang J; Kyondo J; Mulei S; Tumusiime A; Lubwama B; Nyakarahuka L; Klena JD; Lutwama J; Strӧher U; Nichol ST; Shoemaker TR
    Int J Infect Dis; 2018 Mar; 68():88-93. PubMed ID: 29382607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of diagnostic performances of ten different immunoassays detecting anti-CCHFV IgM and IgG antibodies from acute to subsided phases of Crimean-Congo hemorrhagic fever.
    Emmerich P; von Possel R; Deschermeier C; Ahmeti S; Berisha L; Halili B; Jakupi X; Sherifi K; Messing C; Borchardt-Lohölter V
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009280. PubMed ID: 33720942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemorrhagic fever with renal syndrome and Crimean-Congo hemorrhagic fever as causes of acute undifferentiated febrile illness in Bulgaria.
    Christova I; Younan R; Taseva E; Gladnishka T; Trifonova I; Ivanova V; Spik K; Schmaljohn C; Mohareb E
    Vector Borne Zoonotic Dis; 2013 Mar; 13(3):188-92. PubMed ID: 23421884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.